Additional experiments revealed that Reelin contributes to MM cancer cell progression by increasing MM cell glycolysis through activation of the Syk/Akt and STAT3 pathways [150] (Fig. 4). The gene discussed is AKT1; the disease is Miyoshi myopathy.